Term ends Feb 24, 2031 · Medium confidence
20-year base term ends Feb 24, 2031
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 9,133,275, US 9,598,490), so the cap could be lower.
Feb 24, 2011
Feb 24, 2031
Jun 6, 2017
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 24, 2011, when application 13/033,723, the earliest non-provisional in its chain, was filed (this one was filed Dec 15, 2015) | Feb 24, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,557,966, US 8,709,432, US 9,133,275, US 9,598,490, US 9,657,100, US 9,670,278, US 9,670,279, US 9,702,881) | resolves to Feb 24, 2031, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 24, 2031 | Medium confidence |
This family
| US 8,557,966 | In force Feb 2031 | Feb 2031 |
| US 9,133,275 | In force no later than Aug 2031 | no later than Aug 2031 |
| US 9,657,100 | In force Feb 2031 | Feb 2031 |
| US 9,670,278 | In force Feb 2031 | Feb 2031 |
| US 9,670,279 | In force Feb 2031 | Feb 2031 |
| US 9,598,490 | In force no later than Feb 2031 | no later than Feb 2031 |
| US 9,670,280 | this patent Feb 2031 | Feb 2031 |
| US 10,301,385 | In force Apr 2031 | Apr 2031 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 30, 2016 Reel 39912, frame 587 | AB, Olga; Tavares, Daniel; Rui, Lingyun; Payne, Gillian; Goldmakher, Viktor S. | ImmunoGen, Inc. | Assignment of Assignor's Interest |
| Apr 6, 2023 Reel 63282, frame 894 | ImmunoGen, Inc.; ImmunoGen Switzerland GmbH | Biopharma Credit PLC | Patent Security Agreement |
| Feb 12, 2024 Reel 66553, frame 109 | Biopharma Credit PLC | ImmunoGen, Inc.; ImmunoGen Switzerland GmbH | Release of Security Interest |
| Feb 12, 2024 reel/frame not recorded | Biopharma Credit PLC | ImmunoGen, Inc. | Release of Security Interest |
| Feb 12, 2024 reel/frame not recorded | Biopharma Credit PLC | ImmunoGen Switzerland GmbH | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,557,966, US 8,709,432, US 9,133,275, US 9,598,490, US 9,657,100, US 9,670,278, US 9,670,279, US 9,702,881, ends no earlier than this term, so it caps nothing.